Published in Clin Med Oncol on March 25, 2008
The hallmarks of cancer. Cell (2000) 113.05
Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer (1972) 35.74
Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry (1998) 5.30
A matter of life and death. Cancer Cell (2002) 4.07
Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet (2000) 3.71
Apoptosis, autophagy, and more. Int J Biochem Cell Biol (2004) 2.39
Increased uptake of the apoptosis-imaging agent (99m)Tc recombinant human Annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis. Clin Cancer Res (2002) 2.31
Past, present, and future of annexin A5: from protein discovery to clinical applications. J Nucl Med (2005) 1.75
Apoptosis and cancer chemotherapy. Cell Tissue Res (2000) 1.41
Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis. N Engl J Med (2004) 1.34
In vivo imaging of apoptosis by 99mTc-Annexin V scintigraphy: visual analysis in relation to treatment response. Radiother Oncol (2004) 1.17
Safety, biodistribution, and dosimetry of 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application. J Nucl Med (2003) 1.14
Plasma membrane alterations and cytoskeletal changes in apoptosis. Exp Cell Res (1997) 1.13
Sequential 99mTc-hydrazinonicotinamide-annexin V imaging for predicting response to chemotherapy. J Nucl Med (2006) 1.12
Prognostic significance of 99mTc Hynic-rh-annexin V scintigraphy during platinum-based chemotherapy in advanced lung cancer. J Clin Oncol (2007) 1.10
Radiation apoptosis of serous acinar cells of salivary and lacrimal glands. Cancer (1991) 1.04
Imaging cyclophosphamide-induced intramedullary apoptosis in rats using 99mTc-radiolabeled annexin V. J Nucl Med (2001) 1.03
Selective uptake of radiolabeled annexin V on acute porcine left atrial thrombi. Circulation (1995) 1.00
Non-invasive in vivo imaging of myocardial apoptosis and necrosis. Eur J Nucl Med Mol Imaging (2003) 0.99
Radiolabeled annexin V imaging: diagnosis of allograft rejection in an experimental rodent model of liver transplantation. Radiology (2000) 0.97
Evaluation of annexin V as a platelet-directed thrombus targeting agent. Thromb Res (1994) 0.95
In vivo imaging of apoptosis in patients with acute stroke: correlation with blood-brain barrier permeability. Brain Res (2006) 0.90
99mTc-HYNIC Annexin-V imaging of tumors and its relationship to response to radiotherapy and/or chemotherapy. Q J Nucl Med Mol Imaging (2007) 0.86
99mTc-annexin-V functional imaging of luminal thrombus activity in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol (2006) 0.85
Radionuclide imaging of acute lung transplant rejection with annexin V. Chest (2000) 0.81
Nuclear medicine imaging for prediction or early assessment of response to chemotherapy in patients suffering from breast carcinoma. Breast Cancer Res Treat (2002) 0.78
Molecular imaging of cancer: the basics. Radiol Technol (2003) 0.77
In vitro radiation-induced apoptosis and tumour response to radiotherapy: a prospective study in patients with non-Hodgkin lymphomas treated by low-dose irradiation. Int J Radiat Biol (1997) 0.77
Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell (1995) 3.02
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2010) 2.31
Sensitivity versus specificity in melanoma imaging using iodine-123 iodobenzamide and indium-111 pentetreotide. Eur J Nucl Med (1994) 2.05
Reliability of sentinel lymph node biopsy for staging melanoma. Br J Surg (2000) 1.71
Gastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2013) 1.68
Radionuclide therapy. Lancet (1999) 1.48
Excision biopsy of breast lesions changes the pattern of lymphatic drainage. Br J Surg (2007) 1.43
Evaluation of mammary lymphoscintigraphy by a single intratumoral injection for sentinel node identification. J Nucl Med (2000) 1.25
Alkyl-lysophospholipids activate the SAPK/JNK pathway and enhance radiation-induced apoptosis. Cancer Res (1999) 1.18
High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas. J Clin Oncol (2003) 1.17
Bcl-2 is a better ABT-737 target than Bcl-xL or Bcl-w and only Noxa overcomes resistance mediated by Mcl-1, Bfl-1, or Bcl-B. Cell Death Dis (2012) 1.14
Localizing the sentinel node in cutaneous melanoma: gamma probe detection versus blue dye. Ann Surg Oncol (1997) 1.13
Palliative effect of metaiodobenzylguanidine in metastatic carcinoid tumors. J Clin Oncol (1996) 1.11
The hidden sentinel node in breast cancer. Eur J Nucl Med Mol Imaging (2002) 1.10
I-123 MIBG and serial radionuclide angiocardiography in doxorubicin-related cardiotoxicity. Clin Nucl Med (1992) 1.09
Differences in outcomes of oesophageal and gastric cancer surgery across Europe. Br J Surg (2012) 1.08
First line targeted radiotherapy, a new concept in the treatment of advanced stage neuroblastoma. Eur J Cancer (1995) 1.05
Radionuclide diagnosis and therapy of neural crest tumors using iodine-131 metaiodobenzylguanidine. J Nucl Med (1987) 1.04
Intraoperative radioguidance with a portable gamma camera: a novel technique for laparoscopic sentinel node localisation in urological malignancies. Eur J Nucl Med Mol Imaging (2009) 0.98
Detection of occult metastasis in squamous cell carcinoma of the penis using a dynamic sentinel node procedure. J Urol (2000) 0.98
Radioiodinated metaiodobenzylguanidine: a review of its biodistribution and pharmacokinetics, drug interactions, cytotoxicity and dosimetry. Eur J Nucl Med (1994) 0.97
Altered lymphatic drainage after lymphadenectomy or radiotherapy of the axilla in patients with breast cancer. Br J Surg (1996) 0.97
Combined diagnostic imaging with 131I-metaiodobenzylguanidine and 111In-pentetreotide in carcinoid tumours. Eur J Cancer (1996) 0.97
Reliability of lymphoscintigraphy in indicating the number of sentinel nodes in melanoma patients. Ann Surg Oncol (2000) 0.96
Sentinel node biopsy for melanoma in the head and neck region. Head Neck (2000) 0.96
Anticancer therapy and apoptosis imaging. Exp Oncol (2012) 0.94
The combined use of radiotherapy and chemotherapy in the treatment of solid tumours. Eur J Cancer (2002) 0.94
A new method to determine dose-effect relations for local lung-function changes using correlated SPECT and CT data. Radiother Oncol (1993) 0.94
Alkyl-lysophospholipids as anticancer agents and enhancers of radiation-induced apoptosis. Int J Radiat Oncol Biol Phys (2001) 0.93
Improved penetration of docetaxel into the brain by co-administration of inhibitors of P-glycoprotein. Eur J Cancer (2004) 0.92
Prognostic factors in transitional cell cancer of the bladder: an emerging role for Bcl-2 and p53. Radiother Oncol (2001) 0.91
Postoperative chemoradiotherapy in gastric cancer -- a Phase I/II dose-finding study of radiotherapy with dose escalation of cisplatin and capecitabine chemotherapy. Br J Cancer (2007) 0.91
Specificity of radioiodinated MIBG for neural crest tumors in childhood. J Nucl Med (1997) 0.91
Toxicity and complications of preoperative chemoradiotherapy for locally advanced rectal cancer. Br J Surg (2010) 0.91
Radioimmunotherapy in medullary thyroid cancer using bispecific antibody and iodine 131-labeled bivalent hapten: preliminary results of a phase I/II clinical trial. Clin Cancer Res (1999) 0.90
Ionizing radiation modulates the TRAIL death-inducing signaling complex, allowing bypass of the mitochondrial apoptosis pathway. Oncogene (2007) 0.89
Impact of non-axillary sentinel node biopsy on staging and treatment of breast cancer patients. Br J Cancer (2002) 0.89
Evidence for early and persistent impairment of salivary gland excretion after irradiation of head and neck tumours. Eur J Nucl Med (1996) 0.88
The role of I-131-MIBG in the diagnosis and therapy of carcinoids. Eur J Nucl Med (1987) 0.88
Scintigraphic assessment of salivary function and excretion response in radiation-induced injury of the major salivary glands. Cancer (1994) 0.88
Results of treatment with 131 I-metaiodobenzylguanidine (131 I-MIBG) in patients with neuroblastoma. Future prospects of zetotherapy. Prog Clin Biol Res (1991) 0.88
Effective palliation by low dose local radiotherapy for recurrent and/or chemotherapy refractory non-follicular lymphoma patients. Eur J Cancer (2005) 0.88
Improved sentinel node visualization in breast cancer by optimizing the colloid particle concentration and tracer dosage. Nucl Med Commun (2001) 0.87
Apoptosis, proliferation and p53, cyclin D1, and retinoblastoma gene expression in relation to radiation response in transitional cell carcinoma of the bladder. Int J Radiat Oncol Biol Phys (2001) 0.86
The effect of ionizing radiation on endothelial tissue factor activity and its cellular localization. Thromb Haemost (1995) 0.85
Clinical experience with radiation enhancement by hyperbaric oxygen in children with recurrent neuroblastoma stage IV. Eur J Cancer (1995) 0.85
Postoperative chemoradiotherapy in gastric cancer--a phase I-II study of radiotherapy with dose escalation of weekly cisplatin and daily capecitabine chemotherapy. Ann Oncol (2009) 0.84
Radiation injury in the human kidney: a prospective analysis using specific scintigraphic and biochemical endpoints. Int J Radiat Oncol Biol Phys (1990) 0.84
Lymphoscintigraphy in oncology: a rediscovered challenge. Eur J Nucl Med (1999) 0.83
Assessment of sucralfate coating by sequential scintigraphic imaging in radiation-induced esophageal lesions. Gastrointest Endosc (1995) 0.83
Influence of hospital type on outcomes after oesophageal and gastric cancer surgery. Br J Surg (2012) 0.83
Renal excretion of meta-iodobenzylguanidine after therapeutic doses in cancer patients and its relation to dose and creatinine clearance. Nucl Med Commun (1995) 0.82
In vitro and in vivo expression of endothelial von Willebrand factor and leukocyte accumulation after fractionated irradiation. Radiat Res (2000) 0.82
Assessment of anthracycline-related myocardial adrenergic derangement by [123I]metaiodobenzylguanidine scintigraphy. Eur J Cancer (1995) 0.82
Reproducibility of lymphoscintigraphy for lymphatic mapping in cutaneous melanoma. J Nucl Med (1996) 0.82
Targeting of meta-iodobenzylguanidine to SK-N-SH human neuroblastoma xenografts: tissue distribution, metabolism and therapeutic efficacy. Int J Cancer (2000) 0.82
Radiation and anticancer drugs can facilitate mitochondrial bypass by CD95/Fas via c-FLIP downregulation. Cell Death Differ (2009) 0.81
The essentials of locoregional control in the treatment of gastric cancer. Scand J Surg (2006) 0.81
Validation of gamma probe detection of the sentinel node in melanoma. J Nucl Med (1997) 0.81
Surgical treatment results of intestinal and diffuse type gastric cancer. Implications for a differentiated therapeutic approach? Eur J Surg Oncol (2013) 0.81
Radiation nephropathy--the link between functional damage and vascular mediated inflammatory and thrombotic changes. Acta Oncol (2001) 0.80
Retrieval of spatial information in Nijmegen high and low responders: involvement of beta-adrenergic mechanisms in the nucleus accumbens. Behav Neurosci (2000) 0.80
Cisplatin-DNA adduct formation in patients treated with cisplatin-based chemoradiation: lack of correlation between normal tissues and primary tumor. Cancer Chemother Pharmacol (2007) 0.80
Radiochemical purity, at expiry, and radiochemical stability of iodine-131 labelled meta-iodobenzylguanidine concentrates for intravenous infusion. Nuklearmedizin (1996) 0.80
[Added value of prone position technique for PET-TAC in breast cancer patients]. Rev Esp Med Nucl (2010) 0.79
N-hexanoyl-sphingomyelin potentiates in vitro doxorubicin cytotoxicity by enhancing its cellular influx. Br J Cancer (2004) 0.79
Radionuclide therapy of neural crest tumors. Med Pediatr Oncol (1987) 0.79
Hypertrophic osteoarthropathy on bone scintigraphy related to a mediastinal tumour of unknown origin imaged by FDG-PET. Eur J Nucl Med Mol Imaging (2003) 0.79
Dynamic studies of lymphocytes labelled with indium-111 during and after treatment with monoclonal anti-idiotype antibody in advanced B cell lymphoma. Br Med J (Clin Res Ed) (1984) 0.79
Compensatory renal response after unilateral partial and whole volume high-dose irradiation of the human kidney. Eur J Cancer (1993) 0.79
A human neuroblastoma xenograft model for [131I]-metaiodobenzylguanidine (MIBG) biodistribution and targeted radiotherapy. Prog Clin Biol Res (1991) 0.79
Immunofluorescence detection of herpes simplex virus type 1 antigen in cerebrospinal fluid cells of experimentally infected mice. J Neurol Sci (1988) 0.79
Detection of lung metastases from osteosarcoma by scintigraphy using 99mTc-methylene diphosphonate. Diagn Imaging (1981) 0.79
Renal excretion of iodine-131 labelled meta-iodobenzylguanidine and metabolites after therapeutic doses in patients suffering from different neural crest-derived tumours. Eur J Nucl Med (1997) 0.79
Usefulness of indium-111 antimyosin scintigraphy in confirming myocardial injury in patients with anthracycline-associated left ventricular dysfunction. Ann Oncol (1994) 0.79
Preliminary experience with thallous chloride T1 201-labeled single-photon emission computed tomography scanning in head and neck cancer. Arch Otolaryngol Head Neck Surg (1996) 0.79
Thallium-201 SPECT in the diagnosis of head and neck cancer. J Nucl Med (1997) 0.79
[(131)I] and [(125)I] metaiodobenzylguanidine therapy in macroscopic and microscopic tumors: a comparative study in SK-N-SH human neuroblastoma and PC12 rat pheochromocytoma xenografts. Int J Cancer (2000) 0.78
Radiosynoviorthesis of the knee: a doubleblind trial of 1 versus 5 mCi Gold-198. Clin Rheumatol (1988) 0.78
Preoperative chemotherapy does not influence the number of evaluable lymph nodes in resected gastric cancer. Eur J Surg Oncol (2012) 0.78
High sensitivity of radiolabelled antimyosin scintigraphy in assessing anthracycline related early myocyte damage preceding cardiac dysfunction. Nucl Med Commun (2002) 0.78
Towards prediction and modulation of treatment response. Radiother Oncol (1999) 0.78
Tumor and therapy associated abnormal changes on bone scintigraphy. Old and new phenomena. Clin Nucl Med (1993) 0.78
Role of thallium-201 total-body scintigraphy in follow-up of thyroid carcinoma. J Nucl Med (1986) 0.77
Serum hemoglobin levels predict response to strontium-89 and rhenium-186-HEDP radionuclide treatment for painful osseous metastases in prostate cancer. Urol Int (2006) 0.77
Iodine-125-MIBG therapy for neuroblastoma. J Nucl Med (1991) 0.77
131I-meta-iodobenzylguanidine in diagnosis and treatment of neuroblastoma. Bull Cancer (1988) 0.77
High-performance liquid chromatographic determination of metaiodobenzylguanidine in whole blood and plasma of cancer patients. J Pharm Biomed Anal (1994) 0.77
Technetium-99m dimercaptosuccinic acid and ifosfamide tubular dysfunction in children with cancer. Eur J Nucl Med (1994) 0.77
Interference of MIBG uptake by medication: a case report. Neth J Med (1995) 0.77
Total-body scintigraphy with 131I-meta-iodobenzylguanidine for detection of neuroblastoma. Diagn Imaging Clin Med (1985) 0.77
Interferon and meta-iodobenzylguanidin combinations in the treatment of metastatic carcinoid tumours. Endocr Relat Cancer (2004) 0.77
Radioimmunoscintigraphy using iodine-131-anti-CEA monoclonal antibodies and thallium-201 scintigraphy in medullary thyroid carcinoma: a case report. J Nucl Med (1990) 0.77
Nuclear medicine in the monitoring of organ function and the detection of injury related to cancer therapy. Eur J Nucl Med (1993) 0.76
The clearance of heat-damaged erythrocytes by the reticulo-endothelial system in systemic lupus erythematosus and rheumatoid arthritis. Rheumatol Int (1984) 0.76
Membrane organization determines barrier properties of endothelial cells and short-chain sphingolipid-facilitated doxorubicin influx. Biochim Biophys Acta (2014) 0.76
High and low responders to novelty and mesolimbic noradrenaline: effects of noradrenergic agents on radial-maze performance. Behav Neurosci (2002) 0.76
Correlative 201Tl SPECT, MRI and ex vivo 201Tl uptake in detecting and characterizing cervical lymphadenopathy in head and neck squamous cell carcinoma. J Nucl Med (1999) 0.76
Penile lymphoscintigraphy for sentinel node identification. Eur J Nucl Med (2001) 0.76
Occult primary tumors of the head and neck: accuracy of thallium 201 single-photon emission computed tomography and computed tomography and/or magnetic resonance imaging. Arch Otolaryngol Head Neck Surg (2001) 0.76